Tracking a leukemia Drug's Real-World use in italy

NCT ID NCT06205498

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how the drug acalabrutinib is used in everyday medical practice for patients with chronic lymphocytic leukemia (CLL), a common adult leukemia. It will follow 151 patients in Italy for up to 5 years to see how long they stay on the treatment and the reasons they might stop. The goal is to gather real-world evidence on the drug's use after its regulatory approval.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Alessandria, 15121, Italy
Research Site

Ancona, 60126, Italy
Research Site

Bari, 70124, Italy
Research Site

Barletta, 76121, Italy
Research Site

Brindisi, 72100, Italy
Research Site

Campobasso, 86100, Italy
Research Site

Catania, 95100, Italy
Research Site

Catanzaro, 88100, Italy
Research Site

Cosenza, 87100, Italy
Research Site

Crema, 26013, Italy
Research Site

Cuneo, 12100, Italy
Research Site

Foggia, 71122, Italy
Research Site

Frosinone, 03100, Italy
Research Site

Genova, 16132, Italy
Research Site

Lecce, 73100, Italy
Research Site

Messina, 98158, Italy
Research Site

Milan, 20122, Italy
Research Site

Milan, 20132, Italy
Research Site

Monza, 20900, Italy
Research Site

Naples, 80131, Italy
Research Site

Padua, 35128, Italy
Research Site

Pagani, 84016, Italy
Research Site

Perugia, 06132, Italy
Research Site

Pescara, 65124, Italy
Research Site

Ravenna, 48121, Italy
Research Site

Reggio Calabria, 89133, Italy
Research Site

Roma, 00133, Italy
Research Site

Roma, 00161, Italy
Research Site

Roma, 00168, Italy
Research Site

Roma, 00184, Italy
Research Site

Roma, 00189, Italy
Research Site

Rozzano, 20089, Italy
Research Site

Salerno, 84078, Italy
Research Site

San Giovanni Rotondo, 71013, Italy
Research Site

Torino, 10043, Italy
Research Site

Torino, 10073, Italy
Research Site

Torino, 10126, Italy
Research Site

Torino, 10154, Italy
Research Site

Tricase, 73039, Italy
Research Site

Varese, 21100, Italy
Research Site

Viterbo, 01100, Italy

Conditions

Explore the condition pages connected to this study.

CHRONIC LYMPHOCYTIC LEUKEMIA